Additional file 1 of Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019

Additional file 1. Additional information including post-match demographic data, most impactful comorbidities, total HCRU, and total all-cause cost data for DM and cDM groups and controls for all study periods is provided in Supplementary Tables S1-S5 (in excel format). Table S1. Baseline Demographic Characteristics (post-match). Table S2. DM Cohort Most Impactful Comorbidities. Table S3. cDM Cohort Most Impactful Comorbidities. Table S4. Total HCRU & All-cause Costs for DM Cohort over 12-, 13-23, 24-35, 36-47 & 48+ Month Follow-Up Periods. Table S5. Total HCRU & All-cause Costs for cDM Cohort over 12-, 13-23, 24-35, 36-47 & 48+ Month Follow-Up Periods.